KBC Group’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-933
| Closed | -$26K | – | 1532 |
|
|
2023
Q1 | $26K | Hold |
933
| – | – | ﹤0.01% | 1478 |
|
|
2022
Q4 | $27K | Hold |
933
| – | – | ﹤0.01% | 1485 |
|
|
2022
Q3 | $25K | Hold |
933
| – | – | ﹤0.01% | 1496 |
|
|
2022
Q2 | $41K | Buy |
+933
| New | +$41K | ﹤0.01% | 1456 |
|
|
2020
Q2 | – | Sell |
-504
| Closed | -$23K | – | 1331 |
|
|
2020
Q1 | $23K | Sell |
504
-14,618
| -97% | -$667K | ﹤0.01% | 1245 |
|
|
2019
Q4 | $909K | Hold |
15,122
| – | – | 0.01% | 926 |
|
|
2019
Q3 | $855K | Buy |
15,122
+12,100
| +400% | +$684K | 0.01% | 923 |
|
|
2019
Q2 | $168K | Buy |
+3,022
| New | +$168K | ﹤0.01% | 1246 |
|
|
2018
Q4 | – | Sell |
-17,877
| Closed | -$1.24M | – | 1385 |
|
|
2018
Q3 | $1.24M | Buy |
+17,877
| New | +$1.24M | 0.01% | 850 |
|